These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32383524)

  • 21. Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
    Brennen WN; Le Magnen C; Karkampouna S; Anselmino N; Bock N; Choo N; Clark AK; Coleman IM; Dolgos R; Ferguson AM; Goode DL; Krutihof-de Julio M; Navone NM; Nelson PS; O'Neill E; Porter LH; Ranasinghe W; Sunada T; Williams ED; Butler LM; Corey E; van Weerden WM; Taylor RA; Risbridger GP; Lawrence MG
    Prostate; 2024 May; 84(7):623-635. PubMed ID: 38450798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor organoids: Opportunities and challenges to guide precision medicine.
    Veninga V; Voest EE
    Cancer Cell; 2021 Sep; 39(9):1190-1201. PubMed ID: 34416168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Road Map for Precision Cancer Medicine Using Personalized Models.
    Picco G; Garnett MJ
    Cancer Discov; 2017 May; 7(5):456-458. PubMed ID: 28461408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
    Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
    Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
    Pyo DH; Hong HK; Lee WY; Cho YB
    Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in patient-derived liver cancer cell models: a step forward for precision medicine.
    Zhang Z; Hui L
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1707-1717. PubMed ID: 37766458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responsible use of organoids in precision medicine: the need for active participant involvement.
    Lensink MA; Jongsma KR; Boers SN; Noordhoek JJ; Beekman JM; Bredenoord AL
    Development; 2020 Apr; 147(7):. PubMed ID: 32253255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
    Xu H; Jiao D; Liu A; Wu K
    J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Applications of Colorectal Cancer Organoids: A Review.
    Ban QY; Li HS; Jiang XX; Liu M; Ge XY; Lu MJ; Guo SY; Chen Y; Lin Q; Xu H; He WQ; Ding N; Zha JM
    J Gastrointestin Liver Dis; 2024 Jun; 33(2):269-277. PubMed ID: 38944855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering prostate cancer in vitro: what does it take?
    Buskin A; Scott E; Nelson R; Gaughan L; Robson CN; Heer R; Hepburn AC
    Oncogene; 2023 Aug; 42(32):2417-2427. PubMed ID: 37438470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
    Guillen KP; Fujita M; Butterfield AJ; Scherer SD; Bailey MH; Chu Z; DeRose YS; Zhao L; Cortes-Sanchez E; Yang CH; Toner J; Wang G; Qiao Y; Huang X; Greenland JA; Vahrenkamp JM; Lum DH; Factor RE; Nelson EW; Matsen CB; Poretta JM; Rosenthal R; Beck AC; Buys SS; Vaklavas C; Ward JH; Jensen RL; Jones KB; Li Z; Oesterreich S; Dobrolecki LE; Pathi SS; Woo XY; Berrett KC; Wadsworth ME; Chuang JH; Lewis MT; Marth GT; Gertz J; Varley KE; Welm BE; Welm AL
    Nat Cancer; 2022 Feb; 3(2):232-250. PubMed ID: 35221336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic.
    Long Y; Xie B; Shen HC; Wen D
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models.
    Costa B; Estrada MF; Mendes RV; Fior R
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
    Van Hemelryk A; Erkens-Schulze S; Lim L; de Ridder CMA; Stuurman DC; Jenster GW; van Royen ME; van Weerden WM
    Cells; 2023 May; 12(10):. PubMed ID: 37408211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell-derived organoids and their application for medical research and patient treatment.
    Bartfeld S; Clevers H
    J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
    Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
    Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.
    Davies AH; Wang Y; Zoubeidi A
    Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.